 WESTPORT, Conn., Nov. 22, 2021 GLOBE NEWSWIRE -- Portage Biotech Inc. NASDAQ: PRTG Portage or the Company, a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, today announced that Chief Executive Officer, Dr. Ian Walters, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference being held on November 29-December 2, 2021. Dr. Walters will give an overview of Portages pipeline and status of current programs, including the companys lead invariant natural killer T cell iNKT agonists, PORT-2 and PORT-3. 